Intellia Therapeutics Inc
F:38I
Intellia Therapeutics Inc
F:38I
Price:
10.7
EUR
-4.46%
Market Closed
Market Cap:
€1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Intellia Therapeutics Inc
F:38I
|
US |
|
W
|
Winnebago Industries Inc
F:WI1
|
US |
|
R
|
Reach PLC
F:MRR
|
UK |
|
B
|
British American Tobacco PLC
F:BMTA
|
UK |
|
H
|
Hudbay Minerals Inc
F:OCKA
|
CA |
|
J
|
J M Smucker Co
XMUN:JM2
|
US |
|
O
|
OneSpan Inc
F:VDY
|
US |
|
Banca Popolare Di Sondrio SpA
F:593
|
IT |
|
A
|
Alamo Group Inc
F:AL3
|
US |
Wall St Price Targets
38I Price Targets Summary
Intellia Therapeutics Inc
Intellia Therapeutics Inc
Wall Street analysts forecast 38I stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 38I is 41.81 EUR with a low forecast of 7.98 EUR and a high forecast of 157.58 EUR.
Lowest Forecast
Price Target
7.98
EUR
25% Downside
Average Forecast
Price Target
41.81
EUR
291% Upside
Highest Forecast
Price Target
157.58
EUR
1 373% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 38I's stock price target?
Price Target
41.81
EUR
41.81
EUR
According to Wall Street analysts, the average 1-year price target for 38I is 41.81 EUR with a low forecast of 7.98 EUR and a high forecast of 157.58 EUR.
What is the Revenue forecast for Intellia Therapeutics Inc?
Projected CAGR
51%
51%
Over the last 10 years, the compound annual growth rate for Revenue has been 27%. The projected CAGR for the next 8 years is 51%.
